CAPASTAT SULFATE (Akorn)
Welcome to the PulseAid listing for the CAPASTAT SULFATE drug offered from Akorn. This Antimycobacterial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn |
NON-PROPRIETARY NAME: | Capreomycin |
SUBSTANCE NAME: | CAPREOMYCIN SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antimycobacterial [EPC] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-08-01 |
END MARKETING DATE: | 0000-00-00 |
CAPASTAT SULFATE HUMAN PRESCRIPTION DRUG Details:
Item Description | CAPASTAT SULFATE from Akorn |
LABELER NAME: | Akorn |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(g/1) |
START MARKETING DATE: | 2009-08-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-080_2b14f1a3-f8d6-45e8-a31a-89dc25d5c7f8 |
PRODUCT NDC: | 17478-080 |
APPLICATION NUMBER: | NDA050095 |
Other CAPREOMYCIN SULFATE Pharmaceutical Manufacturers / Labelers: